Latest filing published 13 May 2013 for Unitedhealth Group INC, €289k.
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +84.9%Entry US$17.90 · Close at T+365 US$33.10
- +23.9%Entry US$20.43 · Close at T+365 US$25.31
- -30.2%Entry US$32.90 · Close at T+365 US$22.97
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lori Sweere: trading record in brief
Lori Sweere discloses dealings in Unitedhealth Group Inc to SEC (Form 4). In total, 80 filings cover trades dated from 28 April 2008 to 10 May 2013.
Market trades split into 4 purchases (€127k) and 19 sales (€6.1M). Sales outweigh purchases by €6.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 46 share grants and 10 option exercises. 2013 to date brings no purchases and 6 sales.
Half of the purchases are above €32k and half below. Ninety days after publication, 4 purchases show a median change of +10.4%, with the price up in 50% of them. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 13 May 2013: an open-market sale of €289k, in Unitedhealth Group Inc. The most recent open-market purchase was published on 4 March 2009, 6,458 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lori Sweere
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares@ US$62.76Common StockSEC:0001209191-13-025825:0
- 12,631 shares@ US$60.87Common StockSEC:0001209191-13-025351:0
- 11,235 shares@ US$61.90Common StockSEC:0001209191-13-025351:1
- 113.98 shares0Common StockSEC:0001209191-13-018853:0
- 11,038 shares@ US$55.20Common StockSEC:0001209191-13-017735:0
- 1,273 shares@ US$57.74Common StockSEC:0001209191-13-008081:0
- 9,503 shares@ US$33.00Common StockSEC:0001209191-13-008081:1
- 7,027 shares@ US$57.74Common StockSEC:0001209191-13-008081:2
- 1,650 shares@ US$57.42Common StockSEC:0001209191-13-008081:3
- 8,714 shares0Common StockSEC:0001209191-13-007400:0
- 1,640 shares@ US$55.77Common StockSEC:0001209191-13-006570:0
- 14,140 shares@ US$29.74Common StockSEC:0001209191-13-006570:1
- 9,758 shares@ US$55.75Common StockSEC:0001209191-13-006570:2
- 4,382 shares@ US$55.67Common StockSEC:0001209191-13-006570:3
- 3,475 shares@ US$53.86Common StockSEC:0001209191-13-000336:0
- 2,775 shares@ US$53.86Common StockSEC:0001209191-13-000336:1
- 60,608 shares0Common StockSEC:0001209191-13-000336:2
- 25,880 shares@ US$54.24Common StockSEC:0001209191-13-000336:3
- 137.59 shares0Common StockSEC:0001209191-12-059355:0
- 134.27 shares0Common StockSEC:0001209191-12-046664:0
- 127.24 shares0Common StockSEC:0001209191-12-035245:0
- 25,455 shares@ US$33.94Common StockSEC:0001209191-12-034729:0
- 19,201 shares@ US$59.42Common StockSEC:0001209191-12-034729:1
- 6,254 shares@ US$60.12Common StockSEC:0001209191-12-034729:2
- 1,946 shares@ US$56.04Common StockSEC:0001209191-12-032849:0
25 of 79 declarations
